Table 4.
Delta variant | Omicron variant | ||||||||
---|---|---|---|---|---|---|---|---|---|
Age group (years) | Target | Primary vaccination ≥180 days median (IQR), N | Primary vaccination <180 days median (IQR), N | Booster dose median (IQR), N | p value | Primary vaccination ≥180 days median (IQR), N | Primary vaccination <180 days median (IQR), N | Booster dose median (IQR), N | p value |
3–17 | ORF1ab | - | 24.0 [20.5;26.1]47 | - | . | - | 23.0 [22.0;25.0]33 | - | . |
N | - | 22.4 [18.5;25.0]47 | - | . | - | 23.0 [21.0;25.0]33 | - | . | |
18–49 | ORF1ab | 22.0 [20.0;26.0]59 | 22.0 [19.8;25.0]52 | 24.0 [22.0;28.0]29 | 0.075 | 23.5 [22.2;27.0]6 | 23.0 [20.5;25.0]23 | 23.0 [23.0;23.0]1 | 0.690 |
N | 21.0 [18.0;25.0]59 | 21.0 [19.0;23.2]52 | 22.0 [20.0;26.0]29 | 0.298 | 24.0 [23.0;28.0]6 | 22.0 [20.0;25.0]23 | 24.0 [24.0;24.0]1 | 0.397 | |
≥50 | ORF1ab | 21.0 [18.5;25.1]51 | 21.0 [18.0;23.9]95 | 21.8 [18.5;25.0]23 | 0.637 | 23.0 [22.0;25.0]5 | 26.5 [24.8;28.2]2 | - | 0.558 |
N | 20.0 [17.0;23.1]51 | 20.0 [17.0;22.1]95 | 22.0 [17.2;23.0]23 | 0.721 | 23.0 [22.0;24.0]5 | 26.0 [25.5;26.5]2 | - | 0.245 | |
All | ORF1ab | 21.7 [19.0;26.0]110 | 22.0 [19.0;24.1]194 | 23.7 [19.8;26.1]52 | 0.124 | 23.0 [22.0;26.5]11 | 23.0 [22.0;25.0]58 | 23.0 [23.0;23.0]1 | 0.873 |
N | 20.9 [18.0;24.3]110 | 21.0 [18.0;23.0]194 | 22.0 [18.0;24.2]52 | 0.452 | 23.0 [22.5;27.0]11 | 23.0 [21.0;25.0]58 | 24.0 [24.0;24.0]1 | 0.558 |